Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Dahlman
Observed names:
A Dahlman,
A. Dahlman,
A.K. Dahlman,
Anna Dahlman (348461),
Dahlman, Anna
Institution:
Genmab (Denmark)
Observed institutions:
Lund University,
Genmab (United States),
Medicon Village,
Symphogen (Denmark),
Alligator Bioscience (Sweden),
Skåne University Hospital,
Genmab (Denmark),
University of Gothenburg
show all 8
ORCID:
0000-0002-5092-5752
Observed ORCID:
0000-0002-5092-5752
OpenAlex ID:
A5002749401
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
2019
·
Anne Månsson Kvarnhammar
, Niina Veitonmäki
, et al.
·
Journal for ImmunoTherapy of Cancer
·
126
PDF
Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
2011
·
Rebecka Hellsten
, Martin Johansson
, et al.
·
PLoS ONE
·
100
PDF
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
2015
·
Helle J. Jacobsen
, Thomas T. Poulsen
, et al.
·
Clinical Cancer Research
·
90
Galiellalactone is a novel therapeutic candidate against hormone‐refractory prostate cancer expressing activated Stat3
2007
·
Rebecka Hellsten
, Martin Johansson
, et al.
·
The Prostate
·
90
Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance
2015
·
Mikkel W. Pedersen
, Helle J. Jacobsen
, et al.
·
Molecular Cancer Therapeutics
·
60
Sym015: A Highly Efficacious Antibody Mixture against MET -Amplified Tumors
2017
·
Thomas Tuxen Poulsen
, Michael Monrad Grandal
, et al.
·
Clinical Cancer Research
·
50
LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer
2010
·
Marcus Thomasson
, Baofeng Wang
, et al.
·
International Journal of Cancer
·
47
PDF
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis
2011
·
Anna Dahlman
, Elton Rexhepaj
, et al.
·
Modern Pathology
·
40
PDF
Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3
2010
·
A Dahlman
, A Edsjö
, et al.
·
Prostate Cancer and Prostatic Diseases
·
31
PDF
Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms
2017
·
Michael M. Grandal
, Serhiy Havrylov
, et al.
·
Molecular Cancer Therapeutics
·
28
A novel care guide for personalised palliative care – a national initiative for improved quality of care
2021
·
Dröfn Birgisdóttir
, Anette Duarte
, et al.
·
BMC Palliative Care
·
18
PDF
In vivoimaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography
2015
·
Carsten H. Nielsen
, Mette M. Jensen
, et al.
·
Oncotarget
·
18
PDF
Thrombin-Derived C-Terminal Peptide Reduces Candida -Induced Inflammation and Infection In Vitro and In Vivo
2021
·
Anna Dahlman
, Manoj Puthia
, et al.
·
Antimicrobial Agents and Chemotherapy
·
17
Induction of IgE antibodies and T-cell reactivity to ovalbumin in rats colonized with Escherichia coli genetically manipulated to produce ovalbumin.
1992
·
A Dahlman
, S Ahlstedt
, et al.
·
PubMed
·
15
The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
2022
·
Michelle H. Nelson
, Sara Fritzell
, et al.
·
Molecular Cancer Therapeutics
·
14
Assessing the impact and risk of immunomodulatory compounds on pregnancy
2025
·
Joanne Kwak-Kim
, Curtis C. Maier
, et al.
·
Journal of Reproductive Immunology
·
11
Cysteine‐rich secretory protein 3 and β‐microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome
2011
·
Agnes Marije Hoogland
, Anna Dahlman
, et al.
·
British Journal of Urology
·
11
Immune Response against Ovalbumin in Rats Colonized with an Ovalbumin-Producing Escherichia coli and the Influence of Feeding Ovalbumin
2009
·
Anna Dahlman
, Esbjörn Telemo
, et al.
·
International Archives of Allergy and Immunology
·
7
Abstract 2380: Preclinical safety and efficacy of a tumor-directed T cell activating 4-1BB x 5T4 ADAPTIR™ bispecific antibody
2019
·
Anna Dahlman
, Michelle Nelson
, et al.
·
Cancer Research
·
5
Early de-risking strategy for biotherapeutics
2024
·
Padma Kumar Narayanan
, Anna Dahlman
, et al.
·
Elsevier eBooks
·
1
Abstract A183: ATOR-1017: A 4-1BB antibody designed for superior safety/efficacy profile in cancer immunotherapy
2019
·
Eva Dahlén
, Anna Rosén
, et al.
·
Cancer Immunology Research
·
1
Abstract 1218: A novel synergistic antibody pair targeting non-overlapping epitopes of MET effectively inhibits MET-driven cancer models
2016
·
Michael M. Grandal
, Thomas T. Poulsen
, et al.
·
Cancer Research
·
1
746 Crisp-3 and B-msp on Prostate Cancer Needle-biopsies Do Not Have Predictive Value for Subsequent Prostatectomy Outcome
2011
·
A.M. Hoogland
, A. Dahlman
, et al.
·
European Urology Supplements
·
1
A Cross-Study Multi-Organ Cell Atlas of Macaca fascicularis Informed by Human Foundation Model Annotation: A Resource for Translational Target Assessment
2026
·
Terezinha M. Souza
, Joshua T. Gamse
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Supplementary Data from The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
2025
·
Michelle H. Nelson
, Sara Fritzell
, et al.
PDF
Show more works
View as search
Works count:
74
Citation count:
783
H-index:
14
I10-index:
17
Year
Topic
Type